MedPath

Theophylline

Theophylline (Anhydrous) Extended-Release Tablets

Approved
Approval ID

c88d2f3e-3478-4ed4-b4da-44dece7818e9

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 6, 2016

Manufacturers
FDA

Carilion Materials Management

DUNS: 079239644

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Theophylline

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68151-4210
Application NumberANDA040560
Product Classification
M
Marketing Category
C73584
G
Generic Name
Theophylline
Product Specifications
Route of AdministrationORAL
Effective DateNovember 8, 2014
FDA Product Classification

INGREDIENTS (1)

THEOPHYLLINE ANHYDROUSActive
Quantity: 600 mg in 1 1
Code: 0I55128JYK
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Theophylline - FDA Drug Approval Details